Avacta Group Plc

AVCT
48,80
3,80 (8,44%)
26 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: Londra
Tipo: Azione Ordinaria
Valuta: GBX

Ultime notizie

Data Ora Fonte Titolo
26/4/202410:51LSEG_RNSAvacta Group PLC Block listing Interim Return REPLACEMENT
26/4/202408:00LSEG_RNSAvacta Group PLC Block Listing Six Monthly Return
23/4/202410:43LSEG_RNSAvacta Group PLC Block Listing Application to AIM
23/4/202408:00LSEG_RNSAvacta Group PLC Notice of Results
22/4/202418:51ALNCNewsTRADING UPDATES: First Tin updates Tellerhauser estimates
22/4/202413:14LSEG_RNSAvacta Group PLC Issue of Equity and Total Voting Rights
09/4/202418:00LSEG_RNSAvacta Group PLC Avacta Reports Data at the AACR Annual..
08/4/202408:00LSEG_RNSAvacta Group PLC AVA6000 Abstract Release by AACR
05/4/202422:30GLOBEAvacta Group - AVA6000 Abstract Release by AACR and Full..
05/4/202422:30UKREGAvacta Group - AVA6000 Abstract Release by AACR and Full..
28/3/202417:00LSEG_NONAvacta Group PLC Investor Webinar
21/3/202411:37ALNCNewsAvacta doses third patient in drug conjugate trial for..
21/3/202408:00LSEG_RNSAvacta Group PLC Update on AVA6000 Phase 1a Clinical Trial..
18/3/202415:31ALNCNewsIN BRIEF: Avacta shareholders give AGM go-ahead to issue new..
18/3/202414:26LSEG_RNSAvacta Group PLC Result of General Meeting
06/3/202408:00LSEG_RNSAvacta Group PLC Avacta Announces AVA6000 Poster at AACR
05/3/202422:30UKREGUpdated Results from Single-Agent Phase 1 Clinical Trial of..
05/3/202418:09ALNCNewsEARNINGS AND TRADING: Harland & Wolff wins major Falklands..
05/3/202408:00LSEG_RNSAvacta Group PLC Result of REX Retail Offer
29/2/202413:18ALNCNewsAvacta increases placing size to GBP26 million thanks to..
29/2/202408:00LSEG_RNSAvacta Group PLC Result of Placing
28/2/202421:31ALNCNewsTRADING UPDATES: Avacta plans fundraise to fund clinical..
28/2/202417:42LSEG_RNSAvacta Group PLC Proposed REX Retail Offer
28/2/202417:41LSEG_RNSAvacta Group PLC Proposed Fundraise to progress Therapeutics
16/2/202408:00LSEG_RNSAvacta Group PLC Share Incentive Plan/Issue of Equity
22/1/202411:51UKREGAvacta Group PLC Issue of Equity and Total Voting Rights
19/1/202410:11ALNCNewsIN BRIEF: Avacta says new head of R&D Coughlin brings "deep..
19/1/202408:00UKREGAvacta Group PLC Appointment of Christina Coughlin
19/12/202313:00GLOBEAppointment of Chief Business Officer
19/12/202310:57ALNCNewsIN BRIEF: Avacta taps biopharma veteran as Therapeutics..
19/12/202308:00UKREGAvacta Group PLC Appointment of Chief Business Officer
13/12/202313:00GLOBEALS-6000-101 Phase 1a Three-Weekly Dose Escalation Safety..
13/12/202312:49ALNCNewsAvacta says study shows cancer treatment AVA6000 working as..
13/12/202308:00UKREGAvacta Group PLC ALS-6000-101 Phase 1a Study Data
04/12/202308:00UKREGAvacta Group PLC Shareholder update to review AVA6000 Phase..
30/11/202310:00GLOBELevicept Appoints Eliot Forster as CEO
27/10/202308:00UKREGAvacta Group PLC Block Listing Six Monthly Return
23/10/202314:30UKREGAvacta Group PLC Issue of Equity and Total Voting Rights
23/10/202314:30PRNUSAnixa Biosciences Appoints Accomplished Medical Oncologist..
18/10/202314:00UKREGAvacta Group PLC Block Listing Application to AIM
05/10/202308:00UKREGAvacta Group PLC Avacta to present at AACR-NCI-EORTC..
05/10/202308:00GLOBEAvacta to present promising new data from Affimer® and..
29/9/202314:30UKREGAvacta Group PLC Director/PDMR Shareholding
28/9/202312:08ALNCNewsIN BRIEF: Avacta loss widens on cost rise but clinical tests..
28/9/202308:00UKREGAvacta Group PLC Interim Results for the Period Ending 30..
20/9/202315:37ALNCNewsTRADING UPDATES: Capital inks contract; Lansdowne becomes..
20/9/202315:00UKREGAvacta Group PLC Issue of Equity and Total Voting Rights
20/9/202308:01UKREGAvacta Group PLC Peel Hunt Appointed as Joint Broker
20/9/202308:00UKREGAvacta Group PLC Appointment Dr.Christina Coughlin as a..
19/9/202314:36ALNCNewsAvacta notes "excellent" safety profile for prospective..
Apertura: 45,00 Min: 45,00 Max: 49,00
Chiusura: 45,00

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network